Asia Pacific Arterial Cannula Market Size & Outlook

The arterial cannula market in Asia Pacific is expected to reach a projected revenue of US$ 9.4 million by 2030. A compound annual growth rate of 5.4% is expected of Asia Pacific arterial cannula market from 2025 to 2030.
Revenue, 2024 (US$M)
$6.9
Forecast, 2030 (US$M)
$9.4
CAGR, 2025 - 2030
5.5%
Report Coverage
Asia Pacific

Asia Pacific arterial cannula market highlights

  • The Asia Pacific arterial cannula market generated a revenue of USD 6.6 million in 2023.
  • The market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
  • In terms of segment, veno-arterial was the largest revenue generating type in 2023.
  • Veno-Arterial is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.

Asia Pacific data book summary

Market revenue in 2023USD 6.6 million
Market revenue in 2030USD 9.4 million
Growth rate5.1% (CAGR from 2023 to 2030)
Largest segmentVeno-arterial
Fastest growing segmentVeno-Arterial
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationVeno-Arterial, Veno-Venous, Arterio-Venous
Key market players worldwideMedtronic PLC, LivaNova PLC, Edwards Lifesciences Corp, Getinge AB ADR, Fresenius Medical Care AG, BD, Nipro Corp, Andocor, Surgical Holdings

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 20.6% of the global arterial cannula market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 9.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Arterial Cannula Market Companies

Name Profile # Employees HQ Website

Asia Pacific arterial cannula market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to arterial cannula market will help companies and investors design strategic landscapes.


Veno-arterial was the largest segment with a revenue share of 43.94% in 2024. Horizon Databook has segmented the Asia Pacific arterial cannula market based on veno-arterial, veno-venous, arterio-venous covering the revenue growth of each sub-segment from 2018 to 2030.


  • Asia Pacific Arterial Cannula Type Outlook (Revenue, USD Million, 2018-2030)
    • Veno-Arterial
    • Veno-Venous
    • Arterio-Venous
  • Asia Pacific Arterial Cannula Patient Type Outlook (Revenue, USD Million, 2018-2030)
    • Neonates
    • Pediatric
    • Adult
  • Asia Pacific Arterial Cannula Application Outlook (Revenue, USD Million, 2018-2030)
    • Respiratory
    • Cardiac
    • ECPR
  • Asia Pacific Arterial Cannula End Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals
    • Ambulatory Surgical Centers
    • Others

Reasons to subscribe to Asia Pacific arterial cannula market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific arterial cannula market databook

  • Our clientele includes a mix of arterial cannula market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific arterial cannula market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific arterial cannula market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific arterial cannula market size, by country, 2018-2030 (US$M)

Asia Pacific Arterial Cannula Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific arterial cannula market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more